CervoMed (CRVO) News Today $7.50 +0.28 (+3.81%) As of 09:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Brokerages Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $22.57July 15 at 2:51 AM | americanbankingnews.comCervoMed Inc. (NASDAQ:CRVO) Given Average Recommendation of "Moderate Buy" by BrokeragesJuly 10, 2025 | marketbeat.comCervoMed Strengthens Leadership with Technical Operations Hire to Advance Neflamapimod Toward Phase 3July 9, 2025 | finance.yahoo.comCervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025July 8, 2025 | finance.yahoo.comCervoMed Announces Late-Breaking Presentations at Alzheimer's Association® International Congress 2025July 8, 2025 | globenewswire.comCervoMed Inc. (NASDAQ:CRVO) Shares Sold by Perigon Wealth Management LLCJuly 2, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 15, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Sees Significant Decrease in Short InterestJune 13, 2025 | marketbeat.comCervoMed's (CRVO) Buy Rating Reiterated at D. Boral CapitalJune 11, 2025 | marketbeat.comCervoMed Announces New Hire to Support Neflamapimod Development and CommercializationJune 10, 2025 | tmcnet.com74,852 Shares in CervoMed Inc. (NASDAQ:CRVO) Bought by Woodline Partners LPMay 29, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Given Average Rating of "Moderate Buy" by AnalystsMay 23, 2025 | marketbeat.comCervoMed Stock Short Interest Report | NASDAQ:CRVO | BenzingaMay 18, 2025 | benzinga.comD. Boral Capital Reiterates Buy Rating for CervoMed (NASDAQ:CRVO)May 15, 2025 | marketbeat.comCervoMed First Quarter 2025 Earnings: Beats ExpectationsMay 15, 2025 | uk.finance.yahoo.comChardan Capital Raises CervoMed (NASDAQ:CRVO) Price Target to $15.00May 14, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Posts Earnings Results, Beats Expectations By $0.04 EPSMay 14, 2025 | marketbeat.comCervoMed Inc. Reports Positive Phase 2b Results for Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies and Plans Phase 3 TrialMay 13, 2025 | nasdaq.comCervoMed Inc.: CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate UpdatesMay 13, 2025 | finanznachrichten.deCervoMed Reports First Quarter 2025 Financial Results and Provides Corporate UpdatesMay 12, 2025 | globenewswire.comCervoMed (CRVO) Expected to Announce Earnings on TuesdayMay 8, 2025 | marketbeat.comCervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 8, 2025 | finance.yahoo.comCervoMed Inc. (NASDAQ:CRVO) Given Consensus Rating of "Moderate Buy" by BrokeragesApril 28, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Short Interest Down 57.8% in MarchApril 18, 2025 | marketbeat.comCervoMed to present results on Phase 2b RewinD-LB studyApril 3, 2025 | markets.businessinsider.comCervoMed (CRVO) Expected to Announce Quarterly Earnings on FridayApril 3, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Given Average Recommendation of "Moderate Buy" by AnalystsApril 2, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Short Interest UpdateMarch 28, 2025 | marketbeat.comFY2025 EPS Estimate for CervoMed Decreased by AnalystMarch 28, 2025 | marketbeat.comCervoMed (CRVO) Projected to Post Quarterly Earnings on FridayMarch 28, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral CapitalMarch 27, 2025 | marketbeat.comCervoMed Announces Oral Presentation at 19th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders (AP/PD™)March 25, 2025 | globenewswire.comCervoMed Inc trading resumesMarch 21, 2025 | markets.businessinsider.comCervoMed Inc trading halted, volatility trading pauseMarch 21, 2025 | markets.businessinsider.comCervoMed Q1 EPS Increased by Brookline Capital ManagementMarch 21, 2025 | marketbeat.comRoth Capital Issues Negative Outlook for CervoMed EarningsMarch 21, 2025 | marketbeat.comEquities Analysts Set Expectations for CervoMed Q1 EarningsMarch 20, 2025 | marketbeat.com3CRVO : Peering Into CervoMed's Recent Short InterestMarch 19, 2025 | benzinga.comIs CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts?March 19, 2025 | msn.comCervoMed (NASDAQ:CRVO) Price Target Raised to $20.00March 19, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Price Target Raised to $21.00 at Canaccord Genuity GroupMarch 19, 2025 | marketbeat.comChardan Capital upgrades CervoMed (CRVO) to a BuyMarch 18, 2025 | markets.businessinsider.comCervoMed price target raised to $20 from $15 at Roth MKMMarch 18, 2025 | markets.businessinsider.comCervoMed price target raised to $21 from $12 at CanaccordMarch 18, 2025 | markets.businessinsider.comCervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right NowMarch 18, 2025 | msn.comCervoMed (NASDAQ:CRVO) Receives "Buy" Rating from D. Boral CapitalMarch 18, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Issues Earnings ResultsMarch 18, 2025 | marketbeat.comCervoMed reports FY24 EPS ($2.02), consensus ($1.85)March 17, 2025 | markets.businessinsider.comCervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdatesMarch 17, 2025 | markets.businessinsider.comCervoMed sees cash runway into mid-2026March 17, 2025 | markets.businessinsider.com Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address CRVO Media Mentions By Week CRVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRVO News Sentiment▼0.870.97▲Average Medical News Sentiment CRVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRVO Articles This Week▼42▲CRVO Articles Average Week Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FDMT News YMAB News ENGN News EPRX News GNFT News OGI News PROK News ALMS News ELDN News CYBN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRVO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CervoMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
